Welcome to LookChem.com Sign In|Join Free
  • or
4-(dipropylamino)-3,5-dinitrobenzoic acid is an organic compound with the chemical formula C13H16N2O6. It is a derivative of benzoic acid, featuring a dipropylamino group attached to the 4-position and two nitro groups at the 3 and 5 positions. This yellow crystalline solid is known for its potential applications in the synthesis of pharmaceuticals and agrochemicals, particularly as an intermediate in the production of certain herbicides and dyes. The compound's properties, such as its solubility and reactivity, make it a valuable component in various chemical processes.

2347-38-8

Post Buying Request

2347-38-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

2347-38-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 2347-38-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,3,4 and 7 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 2347-38:
(6*2)+(5*3)+(4*4)+(3*7)+(2*3)+(1*8)=78
78 % 10 = 8
So 2347-38-8 is a valid CAS Registry Number.

2347-38-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(dipropylamino)-3,5-dinitrobenzoic acid

1.2 Other means of identification

Product number -
Other names 4-dipropylamino-3,5-dinitrobenzoic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:2347-38-8 SDS

2347-38-8Relevant academic research and scientific papers

Antikinetoplastid antimitotic activity and metabolic stability of dinitroaniline sulfonamides and benzamides

George, Tesmol G.,Johnsamuel, Jayaseharan,Delfin, Dawn A.,Yakovich, Adam,Mukherjee, Mitali,Phelps, Mitch A.,Dalton, James T.,Sackett, Dan L.,Kaiser, Marcel,Brun, Reto,Werbovetz, Karl A.

, p. 5699 - 5710 (2007/10/03)

N1-Phenyl-3,5-dinitro-N4,N4-di-n-propylsulfanilamide (1) and N1-phenyl-3,5-dinitro-N4,N4-di-n-butylsulfanilamide (2) show potent in vitro antimitotic activity against kinetoplastid parasites but display poor in vivo activity. Seventeen new dinitroaniline sulfonamide and eleven new benzamide analogs of these leads are reported here. Nine of the sulfonamides display in vitro IC50 values under 500 nM against African trypanosomes, and the most active antikinetoplastid compounds also inhibit the in vitro assembly of purified leishmanial tubulin with potencies similar to that of 2. While several of the potent compounds are rapidly degraded by rat liver S9 fractions in vitro, N1-(3-hydroxy)phenyl-3,5-dinitro-N4,N4-di-n-butylsulfanilamide (21) displays an IC50 value of 260 nM against African trypanosomes in vitro and is more stable than 2 in the in vitro metabolism assay.

Synthesis and evaluation of dinitroanilines for treatment of cryptosporidiosis

Benbow, John W.,Bernberg, Erin L.,Korda, Anna,Mead, Jan R.

, p. 339 - 343 (2007/10/03)

The efficacy of a series of dinitroaniline herbicide derivatives for the treatment of Cryptosporidium parvum infections has been studied. The lead compounds oryzalin (compound 1) and trifluralin (compound 2) have low water solubility (3 ppm) which was alleged to be a major contributor to their poor pharmacokinetic availability. Derivatives of compounds 1 and 2 were synthesized. In these derivatives the functionality at the C-1 amine position or the C-4 position was substituted with groups with various hydrophilicities to determine if a direct relation existed between water solubility and overall activity. The chlorinated precursors of these derivatives were also examined and were found to be less active in the C. parvum assays, a result in direct contrast to earlier work with Leishmania. Enhanced water solubility alone did not overcome the drug availability problem; however, several candidates with similar activities but with toxicities lower than those of the lead compounds were produced.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 2347-38-8